TUMORICIDAL CAPACITIES OF MACROPHAGES PHOTODYNAMICALLY ACTIVATED WITH HEMATOPORPHYRIN DERIVATIVE
暂无分享,去创建一个
[1] R C Benson,et al. Treatment of diffuse transitional cell carcinoma in situ by whole bladder hematoporphyrin derivative photodynamic therapy. , 1985, The Journal of urology.
[2] T. Sery. Photodynamic killing of retinoblastoma cells with hematoporphyrin and light. , 1979, Cancer research.
[3] T. Dougherty. Photodynamic therapy (PDT) of malignant tumors. , 1984, Critical reviews in oncology/hematology.
[4] D. Shaw,et al. Functional characteristics of the macrophage receptors for IgG-Fc and C3: failure to detect C3 receptor-mediated extracellular cytolysis by mouse peritoneal macrophages. , 1984, Cellular immunology.
[5] T. Dougherty. Photodynamic therapy. , 1993, Photochemistry and photobiology.
[6] N. Yamamoto,et al. Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids. , 1987, Cancer research.
[7] J K Hoober,et al. Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. , 1991, European journal of cancer.
[8] C. Elmets,et al. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. , 1986, Cancer research.
[9] R. Straight,et al. SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES , 1989, Photochemistry and photobiology.
[10] B. Bianco. Alteration of Receptor Function upon Macrophage Activation , 1975 .
[11] R. Straight,et al. Systemic immunosuppression induced by peritoneal photodynamic therapy. , 1988, American journal of obstetrics and gynecology.
[12] N. Yamamoto,et al. Activation of peritoneal macrophages by lysophosphatidylcholine. , 1985, Biochimica et biophysica acta.
[13] Z. Cohn,et al. THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY , 1965 .
[14] H. Kato,et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. , 1982, Chest.
[15] R. Andreesen,et al. Lysophosphatidylcholine (Lysolecithin) and its Synthetic Analogues. Immunomodulating and Other Biologic Effects , 1979 .
[16] A. Girotti,et al. Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative. , 1987, Cancer letters.
[17] J. Farber,et al. Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. , 1978, The Journal of biological chemistry.
[18] S. Silverstein,et al. Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation , 1975, The Journal of experimental medicine.
[19] H. Kato,et al. Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer. , 1983, The Journal of urology.
[20] J. Marshall,et al. EFFECT OF PHOTODYNAMIC THERAPY ON ANTITUMOR IMMUNE DEFENSES: COMPARISON OF THE PHOTOSENSITIZERS HEMATOPORPHYRIN DERIVATIVE AND CHLORO‐ALUMINUM SULFONATED PHTHALOCYANINE , 1989, Photochemistry and photobiology.
[21] D. Kessel. SITES OF PHOTOSENSITIZATION BY DERIVATIVES OF HEMATOPORPHYRIN , 1986, Photochemistry and photobiology.
[22] J E Kaufman,et al. Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.
[23] M. Berns,et al. Gynecologic uses of photoradiation therapy. , 1984, Progress in clinical and biological research.
[24] C. Shields,et al. The role of photocoagulation in the management of retinoblastoma. , 1990, Archives of ophthalmology.
[25] J. Shields,et al. Current approaches to the diagnosis and management of retinoblastoma. , 1981, Survey of ophthalmology.
[26] N. Yamamoto,et al. Contribution of Lysophosphatidylcholine-Treated Nonadherent Cells to Mechanism of Macrophage Activation , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[27] S. Silverstein,et al. SEGMENTAL RESPONSE OF THE MACROPHAGE PLASMA MEMBRANE TO A PHAGOCYTIC STIMULUS , 1974, The Journal of experimental medicine.
[28] J. H. Kinsey,et al. Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. , 1983, The Journal of urology.